SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-007613
Filing Date
2024-02-28
Accepted
2024-02-28 16:22:34
Documents
16
Period of Report
2024-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20240223.htm   iXBRL 8-K 35302
2 EX-10.105 ex10105_janonecommonstockp.htm EX-10.105 122719
3 EX-10.106 ex10106_janoneunitpurchase.htm EX-10.106 128854
  Complete submission text file 0001628280-24-007613.txt   470733

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20240223.xsd EX-101.SCH 1929
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20240223_lab.xml EX-101.LAB 25156
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20240223_pre.xml EX-101.PRE 13069
17 EXTRACTED XBRL INSTANCE DOCUMENT jan-20240223_htm.xml XML 2812
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 24695767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)